Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors

Clinical trial NCT04096638 · COMPLETED

Trial details

NCT number: NCT04096638
Sponsor: invoX Pharma Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Head and Neck Squamous Cell Carcinoma Solid Tumor

Start date: 2019-09-23
Primary completion: 2024-07-16
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.